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Abstract The amyloid β (Aβ) peptide is important in the context of Alzheimer’s disease,
since it is one of the major components of the fibrils that constitute amyloid plaques. Agents
that can influence fibril formation are important, and of those, membrane mimics are partic-
ularly relevant, because the hydrophobic part of Aβ suggests a possible membrane activity
of the peptide. We employed spin-label EPR to investigate the aggregation process of Aβ1–
40 in the presence of the sodium dodecyl sulfate (SDS) detergent as a membrane-mimicking
agent. In this work, the effect of SDS on Aβ is studied using two positions of spin label,
the N-terminus and position 26. By comparing the two label positions, the effect of local
mobility of the spin label is eliminated, revealing Aβ aggregation in the SDS concentration
regime below the critical micelle concentration (CMC). We demonstrate that, at low SDS
concentrations, the N-terminus of Aβ participates in the solubilization, most likely by being
located at the particle–water interface. At higher SDS concentrations, an SDS-solubilized
state that is a precursor to the one Aβ/micelle state above the CMC of SDS prevails. We
propose that Aβ is membrane active and that aggregates include SDS. This study reveals
the unique potential of EPR in studying Aβ aggregation in the presence of detergent.
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1 Introduction
The aggregation of amyloid β (Aβ) peptide to fibrils and plaques is the chief indicator
of Alzheimer’s disease [1–6]. The peptide is derived from misprocessing of the amyloid
precursor protein (APP) and comprises a part of the presumed transmembrane section of
APP [3, 5–9], shown schematically in Fig. 1. The two major amyloid β fragments are the
peptides comprising the 40 amino acids shown in Fig. 1, wildtype (wt) sequence, which
is referred to as Aβ1–40, and Aβ1–42. The Aβ1-42 has an additional isoleucine I and an
alanine A extending the C-terminus of Aβ1–40. In solution, the Aβ peptides are disordered
and especially at high concentration their tendency to aggregate into fibrils is high [10].
In the fibrils, Aβ adopts a parallel, β-sheet structure [3, 11]. The potent pathologic effects
of Aβ oligomers provide a compelling reason for elucidating the mechanism(s) leading
to the transformation of monomeric Aβ into toxic oligomers and ultimately larger aggre-
gates [5, 8, 12–16]. Furthermore, agents that can influence aggregation are important, as
recently reviewed in Wa¨rmla¨nder et al. [17]. Membrane mimics are particularly relevant
because membrane activity is one of the mechanisms by which Aβ could damage cells. The
hydrophobic part of Aβ, indicated in Fig. 1, suggests a possible membrane activity of the
peptide.
The sodium dodecyl sulfate (SDS) detergent is a commonly used membrane mimic in
Aβ studies [18–23] because it can be solubilized with Aβ at any desired concentration,
whereas lipids, which constitute real membranes, have to be added as solutions of pre-
formed membrane preparations, such as vesicles. Especially low concentrations of the lipid
and low lipid–peptide ratios are difficult to obtain, since lipids cannot easily be added to
Aβ, unless co-solvents are used. Ternary mixtures of Aβ with co-solvents and lipids have
complex membrane properties and are therefore avoided. In the present study, we use SDS
because we are interested in the Aβ aggregation over the entire concentration regime of the
lipid/detergent, particularly low concentrations, and such studies cannot be performed with
lipids. Also, using SDS enables us to directly compare with solution NMR, a method that
Fig. 1 Overview of Aβ1-40 sequence and constructs. Top: Schematic of Aβ1–40 relative to membrane
location of the amyloid precursor protein (APP) [3, 5–9], membrane dimensions not to scale. Light blue:
hydrophobic part of the membrane, yellow: lipid headgroup region. Middle: Aβ1–40 sequence, bottom left:
constructs used. Red: cysteine used to link MTSL spin label. Bottom right: MTSL-linked to a schematic
protein backbone
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cannot be applied to lipid vesicles. The price to be paid is that detergents form micelles [24–
29], rather than the lipid bilayer membranes that constitute vesicles. Therefore, whenever
we refer in the following to SDS as a membrane-mimicking agent it is meant in the limited
sense described above.
The aggregation of Aβ under the influence of SDS concerns two concentration regimes
[21]. At low concentrations of SDS or low SDS to peptide ratios (D/P), evidence for aggre-
gates was found. These aggregates appeared to have a β-sheet component [16, 20, 21],
suggesting aggregates that possess the secondary structure element of Aβ in the fibrils. Two
different β-sheet containing species were proposed, one present at D/P ratios lower than 11,
the other above D/P 11. In this SDS concentration regime, no solution NMR signals were
detected [21], therefore molecular-detail information about these species is lacking.
Recent small angle X-ray scattering (SAXS) data show that the β-sheet oligomers at
0.9 mM SDS, i.e., below D/P 11, fit a two-cylinder shape with a cylinder radius of 2.7 nm
and are distinct from fibrils [23, 30], and Sambasivam et al. propose from FRET distances
between residues 1 and 10 that the N-terminus is an α-helix or a β-turn rather than an
extended β-sheet [31]. Monomeric Aβ, which can be detected by NMR under these con-
ditions, is in fast exchange with the aggregates, which, by themselves, are NMR-invisible
[23]. At higher SDS concentrations, i.e., the concentration range at and above the critical
micelle concentration (CMC) of SDS in water [24–27, 29] solution NMR signals reappear
and Aβ is found to have an α-helical conformation. A detailed study using solution NMR
[21, 32] revealed that Aβ is monomeric and embedded in an SDS micelle, a model that is
supported also by small-angle X-ray and neutron scattering, FTIR, and CD spectroscopy
[16, 21, 32–38].
Methods that can obtain molecular detail over the entire SDS concentration regime are
sought to unravel how Aβ interacts with lipid mimics and how it is arranged under the var-
ious D/P-regimes. The tool we use is spin-label EPR, which has been used before in Aβ
research [39–41]. For example, it was shown that signatures of the oligomeric Aβ peptide
can be detected by the spin-label EPR methodology [42]. Measurements on tethered Aβ1-
40 were performed to determine monomer properties of this peptide [43]. Isolated Aβ1-42
oligomers were characterized, showing that Aβ-peptides arrange in antiparallel β-sheets
and have a mobile N-terminus and a less mobile middle section [44]. Also, the interac-
tion of Aβ-oligomers with other proteins [45] and fibril structure [46] was tested by EPR.
Here, we study Aβ in the entire concentration regime of SDS, from low SDS concentrations
(D/P = 2.7) to conditions where SDS micelles should be present (D/P = 131), at peptide
concentrations that promote fast and irreversible aggregation in the absence of SDS. The
constructs we investigate are based on the Aβ1-40 sequence, abbreviated in the following as
Aβ40. The nitroxide spin label is attached to cysteines introduced into the Aβ40 sequence,
one at the N-terminus (SL1-Aβ) and, in the second construct, in the middle of the sequence
(SL26-Aβ), see Fig. 1. To avoid line broadening by spin–spin interactions, we use dia-
magnetic dilution [3, 42, 47]. Diamagnetic dilution refers to diluting the spin-labeled Aβ
peptide (SL-Aβ) with unlabeled Aβ peptide (wild-type Aβ). These Aβ-mixtures are incu-
bated with SDS at various concentrations. The SDS concentrations were chosen to overlap
with the detergent/peptide (D/P) ratios employed by Wahlstro¨m et al. [21].
We show that by EPR we obtain information on the state of Aβ in situ, and over the entire
SDS concentration regime. In particular, we address the NMR-silent regime at intermediate
SDS concentrations and provide structural features of the two β-sheet forms at these SDS
concentrations. At SDS concentrations above the CMC, the monomeric Aβ40 bound to
the micelle state, also found in previous studies [21, 23], is recovered. In the NMR-blind
regime at lower SDS concentrations we show that peptide-detergent aggregates are formed,
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in which the shape and location of the Aβ depends strongly on the detergent–peptide (D/P)
ratio. Apparently, the N-terminus is involved in these aggregates. We also propose detergent-
like action of Aβ at low SDS concentrations.
2 Materials and methods
The Aβ40 peptide as well as two cysteine-Aβ40 variants: [cys26] –Aβ40 and [cys1] –
Aβ40, differing in the position of the spin label, were purchased from AnaSpec (purity
> 95%), the solvent DMSO was purchased from Biosolve (purity 99.8%), the spin
probe MTSSL [1-Oxyl-2,2,5,5-Tetramethyl--Pyrroline-3-Methyl] Methanethiosulfonate
was purchased from Toronto Research Chemicals Inc. (Brisbane Rd., North York, Ontario,
Canada, M3J 2J8). Spin labeling was performed and the purified spin-labeled Aβ was ana-
lyzed by liquid chromatography and liquid chromatography/mass spectrometry as described
previously [42]. The spin-labeled construct thus obtained is referred to as SL1-Aβ or
SL26-Aβ. The peptide was lyophilized and stored in the freezer (–20 ◦C) until used.
2.1 Sample preparation protocol
Two cysteine variants of the Aβ peptide, SL1-Aβ and SL26-Aβ, varying in the position of
the spin label were used. From each Aβ peptide variant, six different Aβ sample conditions,
differing in SDS concentrations (1.5, 3, 4, 7, 36, and 72 mM) were prepared and compared
to a sample to which no SDS was added. The total peptide concentration was kept con-
stant at 0.55 mM. The peptide was a mixture of wild-type Aβ and SL-Aβ, which contained
14% SL-Aβ, resulting in diamagnetically diluted samples as reported before [42]. In con-
trast to the previous protocol [42], we prepared the Aβ samples using a procedure which
involves predissolution of the peptide in dilute base solution [21, 48, 49]. This procedure
was designed to avoid peptide aggregation in the starting solution.
Accordingly, the Aβ peptides were predissolved in NaOH solution (10 mM, pH 11) with
sonication for 1 min in an ice bath at twice the desired final concentration, i.e., at 1.1 mM
total Aβ concentration. The desired amount of SDS was dissolved in potassium phosphate
buffer (20 mM, pH 7.4). The basic solution of Aβ peptides (1.1 mM) was combined with
the potassium phosphate buffer solution (20 mM, pH 7.4) to reach the final desired peptide
concentration and the proper detergent to peptide (D/P) molar ratio for each sample. In the
remainder of the text, we use the detergent-to-peptide (D/P) ratio to refer to each sample
condition, i.e., D/P = 0, 2.7, 5.4, 7.3, 12.7, 65.4, and 130.9, which refers to [SDS] = 0, 1.5,
3, 4, 7, 36, and 72 mM, respectively (see Table 1). This step was followed by another 1-min
sonication in an ice bath. The final pH was adjusted to pH 7.4. The entire sample preparation
was performed on ice and took a few minutes. All samples were prepared and measured at
least twice. To make sure that the sample state did not change in the accumulation period, the
EPR signal amplitude was occasionally checked after the accumulation. Measurements on
aged samples, e.g., after 10 days or 2 weeks, did not reveal any change in the EPR spectra.
2.2 EPR experiments
The X-band continuous wave (cw) EPR measurements have been performed at room tem-
perature (20 ◦C) using an ELEXSYS E680 spectrometer (Bruker, Rheinstetten, Germany)
equipped with a rectangular cavity. Samples of 10–15 μl peptide solution were drawn into
Blaubrand 50-μl capillaries. Often, a white precipitate was observed. In cases where a white
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Table 1 Correspondence of SDS
content of samples. Ratio of SDS
detergent to Aβ peptide (D/P)
and corresponding absolute SDS
concentrations
D/P ratio SDS [mM]
0 0
2.7 1.5
5.4 3
7.3 4
12.7 7
65.4 36
130.9 72
precipitate was observed, the sample height was carefully adjusted in order to be sensitive
to that part of the solution. Measurements were performed using the following parameters:
6.31 mW of microwave power, a modulation amplitude of 1.4 G, and a modulation fre-
quency of 100 kHz. The large modulation amplitude helps to obtain a better signal-to-noise
ratio for broad lines. The accumulation time for the spectra was 40 min per spectrum.
2.3 The amount of spin label in different samples
For a quantitative comparison of samples, we need to investigate the actual amount of
spin label in each sample. This amount was determined by double integration of the first-
derivative EPR spectrum, with the SL-Aβ stock solution as a reference. The amount of spin
label for the samples with different concentrations of SDS was at least 86% compared to
the stock solution. The uncertainties of this method, determined by multiple independent
analyses of the same data, are around 20% due to difficulties with the baseline correction of
the spectra. Within this error margin, the amount of spin-labeled peptides in all samples is
identical.
2.4 Simulations of EPR spectra
MATLAB (version 7.11.0.584, Natick, MA, USA) and the EasySpin package [50] were
used for the simulation of EPR spectra. For all simulations, the following tensor values
were used: g = [2.00906, 2.00687, 2.00300] [42, 51] and Axx = Ayy = 12 and 13 MHz in
DMSO and buffer, respectively. For the fast and medium components, different Azz values
were used than for the slow component, as discussed before [42]. For each fraction, over-
modulation effects were taken into account in EasySpin. Usually, a superposition of 1–3
components was required to simulate the spectra. In all cases, isotropic rotation of the spin
label was sufficient to reproduce the line shape observed.
We interpreted τr with the Stokes–Einstein equation, which implies a spherical approxi-
mation for the volume [42]:
τr = 4πηα
3
3kT
= η
kT
VEPR. (1)
The Boltzmann constant, k, and solvent viscosity, η, at a specified temperature, T, are
required to obtain the hydrodynamic radius, α. According to (1), the volume, VEPR, of the
particle is linearly correlated with the τr of the spin-labeled peptide. The volumes derived
are referred to as VEPR in the text. The volume VEPR derived from τr is strongly affected
by the mobility of the nitroxide group of the spin label and the rotation of the spin label
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around the linker bond can make this correlation time significantly smaller than that of the
aggregate.
3 Results
The spectra of both SL-Aβ variants in DMSO, in which the Aβ peptide is in the monomeric
form [52–54], have three narrow lines (Fig. 2, inset). At low field, the first two lines of both
SL-Aβ variants in DMSO have similar intensities, whereas the intensity of the third line at
high field is larger for the sample of SL1-Aβ compared to that of SL26-Aβ.
Under aggregation conditions [42], i.e., in buffer and in the absence of SDS (D/P = 0),
the lines of both SL-Aβ variants are broadened and additional lines are observed as reported
before [42] (Fig. 2a and 2a’). Under these conditions, fibrils were detected by transmission
electron microscopy [42]. In the presence of SDS, particularly at low concentrations of SDS
(D/P = 2.7, 5.4), the spectra of SL1-Aβ differ from those of SL26-Aβ (Fig. 2a–c and 2a’–
c’), whereas at higher concentrations (above 7 mM, D/P = 12.7), both SL-Aβ variants have
identical spectra (Fig. 2f and 2f’). At D/P ratios of 7.3 and 12.7, the spectrum of SL1-Aβ
has narrower lines compared to those of SL26-Aβ.
By means of simulation, we quantify the spectral changes. The spectra of both SL-Aβ
variants in DMSO are simulated by a single component with a τr value of 0.19 ns for SL1-
Aβ and 0.27 ns for SL26-Aβ. So even though the SL1-Aβ sequence is longer by one residue
than SL26-Aβ, SL1-Aβ has a shorter correlation time. We attribute the difference in the
τr values to a slightly lower local mobility of the spin label at position 26 compared to
that at position 1. The spectra of both SL-Aβ variants in PBS and in the absence of SDS
detergent are simulated using three components which, in the remainder of the text, we
Fig. 2 Room-temperature EPR spectra of SL1-Aβ and SL26-Aβ in PBS for samples with different SDS
detergent to peptide (D/P) ratios. a–f Spectra for SL1-Aβ samples. From a to f, the D/P ratio increases. a’ to
f’: Spectra for SL26-Aβ samples organized as in the left part of the figure. Black line: experiment, red line:
simulation. The inset shows the spectra in DMSO where Aβ is monomeric. I: SL1-Aβ (rotation-correlation
time τr 0.19 ns), II: SL26-Aβ (τr 0.27 ns)
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Table 2 EPR parameters obtained from the simulation of cw EPR spectra of the SL1-Aβ samples
Fast Medium Slow
D/P τra Azz lw %b τr Azz lw % τr Azz lw %c
(ns) (MHz) (MHz) (ns) (MHz) (MHz) (ns) (MHz) (MHz)
0 0.19 110 0.14 10 2.55 ± 0.35 110 0.32 51 > 50 95 0.50 39
2.7 0.43 110 0.14 2.5 4.80 ± 0.40 110 0.32 64 > 50 95 0.50 33.5
5.4 0.43 110 0.14 2.5 4.65 ± 0.55 110 0.32 75 > 50 95 0.50 22.5
7.3 0.19 110 0.14 10 1.76 ± 0.16 110 0.14 90 – – – –
12.7 0.19 110 0.14 7 1.55 ± 0.08 110 0.14 92 – – – –
65.4 – – – – 0.93 ± 0.03 110 0.06 100 – – – –
130.9 – – – – 0.93 ± 0.03 110 0.06 100 – – – –
Given are: τr, rotation-correlation time, Azz, the hyperfine splitting along the z-direction, lw, the component
line width of the simulation and % stands for the contribution of the component to the total spectrum
aErrors: ± 0.02 ns
bErrors: ± 1%
cErrors: ± 4.00%
refer to as fast, medium, and slow. Each component is characterized by its τr value, and the
amount by which this component contributes to the spectrum (Tables 2 and 3). As discussed
previously [42], including additional components in the fit does not significantly improve
the agreement with the experimental data. Therefore the spectra are interpreted as containing
three components or less. The τr values of the components agree well with those found
previously [42]. In the present study, a larger amount of monomeric Aβ (10 vs. 5%) was
found compared to [42], which we ascribe to the different preparation protocol [21, 48, 49],
a protocol that was designed to increase the amount of monomeric Aβ.
Table 3 EPR parameters obtained from the simulation of cw EPR spectra of the SL26-Aβ samples
Fast Medium Slow
D/P τra Azz lw %b τr Azz lw %b τr Azz lw %c
(ns) (MHz) (MHz) (ns) (MHz) (MHz) (ns) (MHz) (MHz)
0 0.27 110 0.14 6 3.6±0.10 110 0.32 52 > 50 95 0.50 42
2.7 0.26 110 0.14 24 2.1±0.10 110 0.32 36 > 50 95 0.50 40
5.4 0.26 110 0.14 13 2.1±0.10 110 0.32 74 > 50 95 0.50 13
7.3 0.26 110 0.14 4 2.1±0.10 110 0.14 96 – – – –
12.7 0.27 110 0.14 7 1.4±0.10 110 0.14 93 – – – –
65.4 – – – – 0.93±0.03 110 0.06 100 – – – –
130.9 – – – – 0.93±0.03 110 0.06 100 – – – –
Given are: τr, rotation-correlation time, Azz, the hyperfine splitting along the z-direction, lw, the component
line width of the simulation and % stands for the contribution of the component to the total spectrum
aErrors: ± 0.02 ns
bErrors: ± 1%
cErrors: ± 4.00%
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To illustrate the sensitivity of the EPR line shape to the rotation correlation time, it is
instructive to compare the spectra I, II, f and f’ in Fig. 2. These spectra concern a sin-
gle mobility component each, and the respective correlation times are 0.19 ns (spectrum
I), 0.27 ns (spectrum II) and 0.93 ns (spectra f and f’). Comparing I and II, a broadening
of the high-field line is visible from the decrease in line intensity, showing that differ-
ences of 80 ps in rotation correlation times already cause differences in line shapes that
can discerned by the naked eye. Obviously, also the larger differences in rotation correla-
tion times of I and II with respect to f and f’ is easy to distinguish by the broadening of the
high-field line.
In the following, we first explain the interpretation of the rotation correlation times,
then describe development of the amount of the three mobility fractions, and next the
corresponding τr values.
3.1 Interpretation of rotation correlation times
According to the Stokes–Einstein equation, Eq. 1, the volume of the particle has a linear
dependence on τr (see Section 2), therefore, from τr we can determine the EPR derived vol-
ume of the aggregates, VEPR, (see Section 2). For the volume of the slow component (τr >
50 ns), only a lower limit of 48,000 A˚3 could be given because this component is immo-
bile on the time scale of the EPR experiment. For the fast-rotating fraction of the sample
with D/P = 0, a τr of 0.19 ns and 0.27 ns for SL1-Aβ and SL26-Aβ is obtained, respec-
tively. Using the viscosity of water of η = 1.002*10−3 (N·s·m−2) at 20 ◦C [55], a volume of
180 A˚3 results, which is close to the volume of 126 A˚3 obtained from the τr of Aβ in DMSO
(η = 1.996*10−3 N·s·m−2 [55], τr = 0.26 ns) in which the peptide is in the monomeric form.
Following Sepkhanova et al., the fast component is assigned to the monomeric peptide [42].
As described before, the τr values contain a contribution of the local mobility of the spin
label that is due to the rotation of nitroxide-containing ring about the single bonds by which
the nitroxide is attached to the peptide backbone (see Fig. 1). This motion is fast compared
to the rotation of the aggregates, and therefore dominates the τr values. Therefore, τr val-
ues are sensitive reporters of the local environment of the spin label, but not of the size of
the aggregate.
3.2 Effect of SDS on the amount of different components
Figure 3 shows the development of the amount by which each mobility component con-
tributes to the spectra as a function of the SDS concentration. In the absence of SDS
(D/P = 0), the spectra of both SL-Aβ variants are composed of almost equal amounts of the
slow and the medium component and a small amount (about 10%) of the fast component.
At low concentrations of SDS (between D/P = 0 and 5.4), the development of the amount
of the fast and the medium components of SL26-Aβ is different from that of SL1-Aβ. For
SL1-Aβ the amount of fast component decreases and the amount of the medium component
increases, whereas SL26-Aβ shows the opposite trend (Fig. 3). In the same concentration
region (between D/P = 0 and 5.4), the amount of the slow component decreases in both SL-
Aβ variants. Above a D/P ratio of 5.4, the slow component has disappeared, leaving only
the fast and medium components. At higher concentrations of SDS (above 7 mM SDS, i.e.,
D/P = 12.7), which is close to the critical micelle concentration (CMC) of neat SDS in water
[24–29], only one component of medium mobility is left, which has the same parameters
for both SL-Aβ variants.
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Fig. 3 Amount of the spectral components as a function of the SDS concentration, expressed as the D/P
ratio. a SL1-Aβ. b SL26-Aβ
3.3 Effect of SDS on the rotation correlation time
The τr-values of the fast component of the EPR spectra of SL1-Aβ and SL26-Aβ in buffer
are identical to those of the respective SL-Aβ variants in DMSO, showing that the fast
fraction should be monomeric Aβ. In the presence of SDS, up to D/P = 5.4 the τr-values
of the fast and the medium component of SL1-Aβ are larger than those of SL26-Aβ. For
SL1-Aβ, at D/P <7.3, the τr-values of both fast and medium components slightly increase
with increasing SDS concentration, whereas those for SL26-Aβ remain constant over that
range (D/P <7.3). At higher values of D/P (above D/P = 12.7; i.e., 7 mM SDS), no fast
component is detected in the spectra of both SL-Aβ variants. The τr-values of the only
observed component in both SL-Aβ variants are identical. This τr is longer than the τr of
both SL-Aβ variants in DMSO, in which the Aβ peptide is in the monomeric form.
3.4 Is the species observed at high SDS concentrations monomeric?
To test for spin–spin interaction, we measured a pure SL-Aβ sample at a D/P ratio of 130.9.
The result is shown in Fig. 4. There is no difference between the diamagnetically diluted
and the non-diluted sample, showing that there is no spin–spin interaction between the Aβ
peptides in that state.
4 Discussion
We have investigated the properties of Aβ in the presence of different concentrations of
SDS. We propose that the state of Aβ changes in a continuous fashion as a function of SDS
concentration and that there are different types of aggregates at SDS concentrations below
the CMC.
4.1 The state of Aβ in the absence of SDS
In the absence of SDS, the EPR spectra consist of three components and match closely those
described in our earlier study [42]. As described before [42], at these high concentrations
of Aβ, the peptide aggregates fast. In the time of several minutes that it takes to prepare
the sample, the peptide is already fully aggregated, and the EPR spectra do not change
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Fig. 4 Spectra demonstrating the absence of spin–spin interaction in the high-SDS form of Aβ. At a D/P
ratio of 130.9, pure SL1-Aβ (black line) has the same spectrum as diamagnetically diluted Aβ (red, dashed
line: dd-SL1-Aβ)
with time. According to transmission electron microscopy (TEM) on wt-Aβ40 and different
mixtures of Aβ40 with SL-Aβ, which we had published earlier [42], aggregates and fibrils
are present, and the solutions were Congo red active, confirming the presence of fibrils. We
also proved that the three-component EPR spectra such as shown in Fig. 2a are correlated
with fibrils [42]. Analogous to the previous study [42], we refer to the three components in
the EPR spectra as the fast, medium, and slow components. We attribute the fast component
to monomeric Aβ and the two others to aggregated forms of Aβ. Since both in buffer and
in DMSO, monomeric SL1-Aβ has a smaller τr than SL26-Aβ, we conclude that the central
region of Aβ is less flexible than the N-terminus.
The ratio of the fractions shows that the largest portion of the sample is aggregated,
as maximally 12% of the fast, monomeric fraction is found. This observation is in good
agreement with previous reports on the concentration dependence of the Aβ aggregation
[10, 21]. In Aβ preparations made specifically to keep Aβ monomeric by tethering, no EPR
signals equivalent to our slow fraction are detected (Gu et al. [43]), emphasizing that the
slow fraction is aggregated Aβ.
4.2 The high-SDS state: Aβ at SDS concentrations above the CMC
At high concentrations of SDS, Aβ occurs as a single species, referred to as the high-SDS
species. Since these SDS concentrations are well above the CMC of SDS in water [24–29],
it stands to reason that SDS is in the micellar form also in the solutions investigated here.
The high-SDS-Aβ species represents at least 80% of the total peptide in the sample (see
Section 2) and is the only species we observe. Under these conditions, Aβ is monomeric, as
proven by the absence of spin–spin interaction in spectra of pure, i.e., non-diamagnetically
diluted, SL-Aβ (Fig. 4). The τr of this species is longer than that of the monomeric (fast)
fraction of Aβ in the absence of SDS, showing that the spin-label of Aβ is interacting with
the micelle. Even though longer than the τr of the monomeric species, the τr never becomes
as long as that expected for rotational diffusion of the SDS micelle [24, 56] or rotational
diffusion times determined from NMR results of Aβ bound to micelles [21, 36, 38], showing
that the spin label has local degrees of freedom. These local degrees of freedom derive from
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rotations around the single bonds linking the nitroxide to the peptide backbone (see Fig. 1).
Identical τr values for the N-terminus and the central position of Aβ indicate that the N-
terminus and the central part of Aβ have similar local interactions with the micelle. The idea
of monomeric Aβ bound to a micelle is fully consistent with the results of other techniques
[18, 21, 23, 32, 33, 35, 36, 38].
Our experiments, which show a homogeneous, non-interacting species of Aβ at these
high SDS concentrations, cast new light on previous NMR-titration data, which, at simi-
lar D/P ratios, revealed that Aβ is heterogeneous, and only a fraction of about 20% of the
Aβ was visible to NMR, i.e., monomeric [21]. The most likely explanation is that titration
is less effective in breaking up aggregates than incubating Aβ directly with the final, high
concentration of SDS, as done in the present study. A second factor could be that the abso-
lute concentrations of NMR and EPR are not the same: The peptide concentration in the
Section 2.2 is higher than in NMR, and consequently, the CMC of SDS is reached at lower
D/P ratios than in the NMR experiments. This could help to favorably influence the equi-
librium between Aβ-Aβ and Aβ-SDS interaction [18] and result in a larger fraction of
monomeric Aβ bound to the micelle in the EPR compared to the NMR experiment. Further
information from SAXS data suggests that Aβ is bound to the micelle-headgroup region
[23].
4.3 Development of aggregate species at SDS concentrations below the CMC
In contrast to the interpretation of the high-SDS-species, much less is known so far about the
state of the peptide at intermediate concentrations of SDS. To determine which aggregates
are present at different SDS concentrations, we need to reduce the influence of the spin-
label mobility on the data. Adding the amounts by which the fast and medium fractions
contribute to the spectra at each SDS concentration such a measure is obtained, as shown in
the plot in Fig. 5.
Fig. 5 Amount of the spectral components as a function of the D/P ratios. The lines joining the points
represent the amount of the slow (filled triangles: SL26-Aβ, non-filled triangles: SL1-Aβ) and combined
fast and medium (filled circles: SL26-Aβ, non-filled circles: SL1-Aβ) components of the SL1-Aβ and SL26-
Aβ variants, similar to Fig. 3. In both SL-Aβ variants, the amount of slow component decreases, whereas
the amount of the more mobile components (fast plus medium) increases
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At each SDS concentration, the amount of the faster (fast + medium) and the slow frac-
tion are identical for SL26-Aβ and SL1-Aβ within the experimental uncertainty, whereas
the three fractions taken individually (see Fig. 3a vs. b) differ significantly. Evidently, the
combined fractions in Fig. 5 reflect the state of the sample, rather than differences in local
spin-label mobility. Between D/P ratios of two and ten, a steep increase in the faster frac-
tions (fast + medium in Fig. 5) is accompanied by a decrease in the amount of the slow
fraction, showing that the aggregation state is strongly dependent on the SDS concentration
in that SDS regime. Also, Abelein et al. [23] find the largest changes of CD, pyrene, and
fluorescence data in the narrow SDS concentration regime from 1 to 2 mM SDS. This is
close to the absolute SDS concentrations at which we observe the most pronounced changes
in the EPR spectra.
At the start of the region of the steepest change in the present study, i.e., at a D/P of 2.7,
the combined fractions (Fig. 5) are similar to those in the pure Aβ state; however, locally,
the Aβ seems to take on a different conformation than in the absence of SDS (Fig. 3a
and b). The N-terminus, at a D/P of 2.7, is less mobile than in the absence of SDS, as
evidenced by the larger τr-values (Table 2) of the fast and medium component and the
smaller amount of the fast component of SL1-Aβ. At low SDS-to-peptide ratios, aggregates
should be dominated by Aβ–Aβ interactions and these apparently restrict the mobility of
the N-terminus. Support for involvement of the N-terminus comes from Sambasivam et al.
[31], who propose an α-helix or a β-turn for the N-terminus of Aβ, rather than an extended
conformation such as a β-sheet. The central part of Aβ shows the opposite behavior. It is
more mobile than in the absence of SDS and also more mobile than the N-terminus at this
SDS concentration.
As described in Section 1, at SDS concentrations below the CMC, Wahlstro¨m et al. [21]
find two β-sheet-type oligomeric structures, with a transition point around a D/P ratio of 11,
i.e., an SDS concentration of 1.6 mM or D/P of 3 in our study. Our results suggest that in the
first species, observed at lower SDS concentrations [21], the N-terminus is trapped in the
aggregate. Since most [57–60], but not all [61] Aβ fibril models place the N-terminus out-
side the fibril core, this suggests a non-fibril-like β-sheet oligomer. Also, TEM and SAXS
data argue against a fibril-like shape for these aggregates [23]. The results of NMR show
that at these SDS concentrations the monomers are in fast exchange with the aggregates,
which, by themselves, are NMR-invisible. On the EPR timescale, the fast mobility frac-
tion, attributed to monomers, is in slow exchange with the aggregates, in agreement with
faster time-scale of EPR compared to NMR. The structural features of Aβ in the different
aggregation states are summarized in the next section.
4.4 Indications for conformation of Aβ in the SDS oligomers
To illustrate our emerging view of Aβ aggregate development in the presence of SDS, we
sketch structural features of Aβ-SDS interaction derived from EPR in Fig. 6. At lower D/P
ratios, left hand sketch in Fig. 6 (for details, see figure caption), the N-terminus is buried in
the aggregate. Since it is hydrophilic [62], and in most of the models [57–60] is not involved
in the β-sheet area of the Aβ-fibrils, we propose that the most likely location of the N-
terminus is at the water/aggregate interface, which helps to solubilize the aggregate. The
sketch in Fig. 6 shows a possible way how the central part of Aβ could be more mobile under
these conditions: The hydrophobic tails of SDS could bind to the hydrophobic aggregation
domains of Aβ (residues 25-35) [63], while the hydrophilic head-groups of SDS enable
solubilization towards the aqueous surroundings, thereby freeing the central region of Aβ
from the aggregate. At intermediate D/P ratios, middle sketch in Fig. 6, the N-termini of Aβ
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Fig. 6 Illustration of the Aβ aggregation at different D/P ratios. On the left side, the Aβ aggregate is shown
at a D/P of about 5.4, in which the hydrophilic N-terminus becomes immobilized at the aggregate–buffer
interface. This helps to solubilize the aggregate. In the middle, the Aβ aggregate is shown at D/P ratios of
about 7.3, where there are sufficient SDS molecules to replace (some of) the Aβ N-termini at the water–
aggregate interface. On the right, the Aβ peptide is shown at D/P ratios above the CMC of SDS. Two possible
models for Aβ interaction with a micelle are shown, in which both spin labels would have similar rotation
correlation times
are liberated from the aggregate, presumably because in that concentration regime there are
sufficient SDS molecules to provide a hydrophilic cover for the aggregate. The central part
of Aβ, however, becomes trapped in the centre of the Aβ-SDS aggregate. The right-side
sketch in Fig. 6 illustrates the micelle-bound form of Aβ, the high-SDS species. Similar
rotation-correlation times at the N-terminus and the central part of Aβ could derive from
the N-terminus binding at the micelle-headgroup region of the micelle, while the central
part is located in the middle of the micelle, where the ends of the tails of SDS could provide
wriggling space.
According to Jarvet et al. [32], neither the N-terminus nor the central region of the pep-
tide are part of the helical domain. Therefore, the partial immobilization we observe cannot
be attributed to intramolecular interactions deriving from helix formation, but rather to
interactions with the micelle (see below).
4.5 Evidence for detergent-like action of Aβ
At SDS concentrations below the CMC, not membrane interactions, but individual detergent
molecules, must be responsible for the solubilization of Aβ, i.e., the inhibition of aggre-
gates. Put differently, detergent molecules must be incorporated into the Aβ-aggregates
under these conditions, suggesting a detergent-like behavior of Aβ and the ability of Aβ
or its aggregates to bind detergent molecules. Presumably, the Aβ peptide acts as a kind of
detergent. Support comes from NMR results, which suggest a co-aggregate of detergent and
Aβ with a hydrodynamic radius of 6 nm. A mixture of random-coil and β-sheet is found
and involvement of the Aβ-N-terminus is concluded [23], similar to the present study.
5 Conclusion
Overall, the present EPR investigation suggests that even at low concentrations SDS
can inhibit Aβ aggregation by promoting Aβ-SDS complexes. Since, according to other
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techniques, this change is accompanied by a loss in β-sheet signature and an increase in α-
helix character [21], we propose that this is the first step towards the micelle-bound state of
Aβ, in which the monomeric peptide has an α-helical structure.
Apparently, aggregates bind detergent, which we extrapolate to suggest that there are
forms of Aβ that can be membrane active, and this suggests that they could also bind lipid
molecules, a hypothesis that is supported by the finding of a cholesterol-binding site of the
Aβ-precursor, the APP protein [64, 65]. Whether such aggregates play a role in neuronal
toxicity is one of the many open questions in Aβ research.
In conclusion, we have shown that previously inaccessible detail of the low-SDS form
of Aβ can be obtained by spin-label EPR. A careful study of two labeling positions in Aβ
and the sensitivity of this EPR approach to local mobility reveal a change in the aggregate
state. From a particle, in which the N-terminus of Aβ participates in the solubilization and
is located at the particle–water interface, the aggregate changes to an SDS-solubilized state
that is a precursor to the one Aβ/micelle state above the CMC of SDS. Most striking is
the observation that the N-terminus is active in the low D/P regime, where we suspect tight
detergent–aggregate interaction. If lipid binding proceeds similarly, it may be that mem-
brane interaction in a disease context involves the N-terminus, suggesting this region as a
target to reduce membrane damage by Aβ. We stress that the submicellar SDS regime, in
which Aβ is NMR-silent, mimics a situation that is relevant for the cellular action of Aβ.
[21], namely a high (local) concentration of Aβ close to a membrane. With respect to the
disease, these may well be sites where Aβ aggregation is initiated and our results suggest
that aggregates formed at such sites could be membrane active, enabling us to speculate that
membrane damage may result from such initial aggregates.
We demonstrate how from the local mobility parameters, not only the behavior of the
N-terminal or the central positions of Aβ can be discriminated but also global properties
of the Aβ-aggregation state are obtained, revealing the unique potential of EPR in studying
the Aβ aggregation in situ.
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